These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

355 related items for PubMed ID: 1721976

  • 1. Comparison of the effects of carvedilol, propranolol, and verapamil on in vitro platelet function in healthy volunteers.
    Gasser JA, Betterridge DJ.
    J Cardiovasc Pharmacol; 1991; 18 Suppl 4():S29-34. PubMed ID: 1721976
    [Abstract] [Full Text] [Related]

  • 2. Carvedilol--a beta-blocker with considerable antiaggregatory effect on human blood platelets.
    Petrikova M, Jancinova V, Nosal R, Majekova M, Fabryova V.
    Bratisl Lek Listy; 2005; 106(1):20-5. PubMed ID: 15869009
    [Abstract] [Full Text] [Related]

  • 3. Inhibition of platelet function of antiarrhythmic drugs, verapamil and disopyramide.
    Han P, Boatwright C, Ardlie NG.
    Thromb Haemost; 1982 Apr 30; 47(2):150-3. PubMed ID: 7101234
    [Abstract] [Full Text] [Related]

  • 4. Effect of the calcium-entry blocking agent nifedipine on activation of human platelets and comparison with verapamil.
    Han P, Boatwright C, Ardlie NG.
    Thromb Haemost; 1983 Aug 30; 50(2):513-7. PubMed ID: 6314581
    [Abstract] [Full Text] [Related]

  • 5. Antiplatelet activity of carvedilol in comparison to propranolol.
    Petríková M, Jancinová V, Nosál R, Májeková M, Danihelová E.
    Platelets; 2002 Dec 30; 13(8):479-85. PubMed ID: 12487781
    [Abstract] [Full Text] [Related]

  • 6. Effects of nebivolol on human platelet aggregation.
    Falciani M, Rinaldi B, D'Agostino B, Mazzeo F, Rossi S, Nobili B, Rossi F, Filippelli A.
    J Cardiovasc Pharmacol; 2001 Dec 30; 38(6):922-9. PubMed ID: 11707696
    [Abstract] [Full Text] [Related]

  • 7. Effects of long-acting propranolol and verapamil on blood pressure, platelet function, metabolic and rheological properties in hypertension.
    Ding YA, Chou TC, Lin KC.
    J Hum Hypertens; 1994 Apr 30; 8(4):273-8. PubMed ID: 8021907
    [Abstract] [Full Text] [Related]

  • 8.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 9.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 10.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 11.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 12.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 13. Beta-adrenoceptor antagonists and human platelets: relationship of effects to lipid solubility.
    Kerry R, Scrutton MC, Wallis RB.
    Biochem Pharmacol; 1984 Aug 15; 33(16):2615-22. PubMed ID: 6147145
    [Abstract] [Full Text] [Related]

  • 14.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 15. Effects of propranolol in vitro and in vivo on platelet function and thromboxane formation in normal volunteers.
    Siess W, Lorenz R, Roth P, Weber PC.
    Agents Actions; 1983 Feb 15; 13(1):29-34. PubMed ID: 6344593
    [Abstract] [Full Text] [Related]

  • 16.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 17. Verapamil and collagen-induced platelet reactions--evidence for a role for intracellular calcium in platelet activation.
    Han P, Boatwright C, Ardlie NG.
    Thromb Haemost; 1983 Aug 30; 50(2):537-40. PubMed ID: 6415847
    [Abstract] [Full Text] [Related]

  • 18. Carvedilol, a new vasodilator and beta adrenoceptor antagonist, is an antioxidant and free radical scavenger.
    Yue TL, Cheng HY, Lysko PG, McKenna PJ, Feuerstein R, Gu JL, Lysko KA, Davis LL, Feuerstein G.
    J Pharmacol Exp Ther; 1992 Oct 30; 263(1):92-8. PubMed ID: 1357162
    [Abstract] [Full Text] [Related]

  • 19. ADP-mimicking platelet aggregation caused by rugosin E, an ellagitannin isolated from Rosa rugosa Thunb.
    Teng CM, Kang YF, Chang YL, Ko FN, Yang SC, Hsu FL.
    Thromb Haemost; 1997 Mar 30; 77(3):555-61. PubMed ID: 9066010
    [Abstract] [Full Text] [Related]

  • 20.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 18.